1 |
Numata K. Abdominal Ultrasound and Treatment of Hepatocellular Carcinoma. Diagnostics (Basel) 2021;11:1268. [PMID: 34359352 DOI: 10.3390/diagnostics11071268] [Reference Citation Analysis]
|
2 |
Li J, Zhao S, Ling Z, Li D, Jia G, Zhao C, Lin X, Dai Y, Jiang H, Wang S, Teekaraman Y. Dual-Energy Computed Tomography Imaging in Early-Stage Hepatocellular Carcinoma: A Preliminary Study. Contrast Media & Molecular Imaging 2022;2022:1-8. [DOI: 10.1155/2022/2146343] [Reference Citation Analysis]
|
3 |
Qin Z, Zhou Y, Ding J, Wen J, Chen Y, Zhou H, Jing X. Risk stratification for hepatocellular carcinoma of contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) and the diagnostic performance of LR-5 and LR-M: a systematic review and meta-analysis. Clinical Radiology 2022. [DOI: 10.1016/j.crad.2022.01.041] [Reference Citation Analysis]
|
4 |
Ciocalteu A, Iordache S, Cazacu SM, Urhut CM, Sandulescu SM, Ciurea AM, Saftoiu A, Sandulescu LD. Role of Contrast-Enhanced Ultrasonography in Hepatocellular Carcinoma by Using LI-RADS and Ancillary Features: A Single Tertiary Centre Experience. Diagnostics (Basel) 2021;11:2232. [PMID: 34943474 DOI: 10.3390/diagnostics11122232] [Reference Citation Analysis]
|